À. Munck

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>

Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

Jennifer L. Taylor‐Cousar, À. Munck, Edward F. McKone et al. · New England Journal of Medicine · 2017 · 778 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Absence of Microsomal Triglyceride Transfer Protein in Individuals with Abetalipoproteinemia

John R. Wetterau, Lawrence P. Aggerbeck, Marie-Elisabeth Bouma et al. · Science · 1992 · 759 citations

Life Sciences, Biochemistry, Molecular Biology +14

Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a <i>G551D</i> Mutation

Jane C. Davies, Claire Wainwright, Gerard J. Canny et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 506 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Recommendations for the classification of diseases as CFTR-related disorders

Cristina Bombieri, Mireille Claustres, K. De Boeck et al. · Journal of Cystic Fibrosis · 2011 · 421 citations · Full text

Medicine, Clinical Sciences, Molecular Medicine +11